Ledger.Open graph →
SEC Form D · filed December 17, 2014

Apellis Pharmaceuticals, Inc

Offering
$21.5M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CRESTWOOD, KY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Gerald S. Chan · Newton, MADirectorA. S. Dunlop · Bethesda, MDDirectorPascal Deschatelets · Crestwood, KYExecCedric J. Francois · Crestwood, KYExec · DirectorAlec S. Machiels · Crestwood, KYDirectorStephanie S. O'Brien · Newton, MADirectorGregory M. Friedman · ATLANTA, GAExec · DirectorMathew M. Crosswy · ATLANTA, GAExec · DirectorRobert M. Woomer · ATLANTA, GAExec · DirectorSs Hotel Credit Opportunity Fund, LLC · ATLANTA, GAExec · DirectorDavid Dworsky · Gardena, CADirectorStorm Venture Associates V, L.L.C · MENLO PARK, CADirectorDominic A. Bassani · Crestone, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗